Avanos Medical (AVNS) Revenue (2013 - 2026)

Avanos Medical has disclosed Revenue across 14 years of filings, most recently posting $182.2 million for Q1 2026.

• In Q1 2026, Revenue rose 8.78% year-over-year to $182.2 million; the TTM figure through Mar 2026 stood at $715.9 million (up 3.87% YoY), while the FY2025 annual figure was $701.2 million, up 1.95% from the prior year.
• Revenue came in at $182.2 million for Q1 2026 at Avanos Medical, up from $180.9 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $197.4 million in Q1 2022 to a low of $159.3 million in Q1 2023.
• Average Revenue over 5 years is $174.5 million, with a median of $172.3 million recorded in 2022.
• Year-over-year, Revenue soared 407.26% in 2022 and dropped 19.3% in 2023.
• Over 5 years, Revenue stood at $181.6 million in 2022, then decreased by 4.57% to $173.3 million in 2023, then gained by 3.64% to $179.6 million in 2024, then advanced by 0.72% to $180.9 million in 2025, then increased by 0.72% to $182.2 million in 2026.
• Per Business Quant data, the three most recent Revenue figures were $182.2 million in Q1 2026, $180.9 million in Q4 2025, and $177.8 million in Q3 2025.